Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval - Université de Rennes
Article Dans Une Revue Rheumatology Année : 2019

Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval

Domaines

Sciences du Vivant [q-bio]

Laurent Jonchère  : Connectez-vous pour contacter le contributeur

https://univ-rennes.hal.science/hal-02179667

Soumis le : jeudi 11 juillet 2019-09:24:37

Dernière modification le : vendredi 11 octobre 2024-03:20:42

Fichier non déposé

Dates et versions

hal-02179667 , version 1 (11-07-2019)

Identifiants

Citer

Tristan Pascart, Laurène Norberciak, Hang-Korng Ea, Sahara Graf, Pascal Guggenbuhl, et al.. Difficult-to-treat gout flares eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval. Rheumatology, 2019, 58 (12), pp.2181-2187. ⟨10.1093/rheumatology/kez203⟩. ⟨hal-02179667⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-PARIS7 UNIV-RENNES1 UNIV-LITTORAL INRA NUMECAN UR1-UFR-SVE USPC UNIV-RENNES UNIV-LILLE UP-SANTE UR1-BIO-SA MABLAB
42 Consultations
0 Téléchargements

Altmetric

Partager

More